Associated Papers
CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting.
Courtney DG et al.
Gene Therapy, 2016
26289666 (PubMed )
Supplement: gt201582x1.xls › Sheet2
Select a paper to view details